Supported by:
World Health Organization (WHO)

Lead Investigator:

• Dr. Yuvaraj Krishnamoorthy Consultant & Head of Evidence Syntesis Unit

This review assesses the ideal frequency for HbA1c testing to maintain glycemic control and prevent complications in adults with T1DM.

Focus Areas:

• Identify cut-offs that balance risk of long-term complications vs. hypoglycemia
• Inform updated clinical practice guidelines
• Compare outcomes using direct and network meta-analysis